Illumina Acquires Cytogenetics Company BlueGnome

September 19, 2012

September 19, 2012 | Illumina today announced that it will acquire UK company BlueGnome, a cytogenetics company that looks at the structure and function of cells for genetic abnormalities that can lead to cancer, developmental delays, or infertility. Xconomy